Zacks Investment Research on MSN
Why Rocket Lab Corporation (RKLB) outpaced the stock market today
In the latest close session, Rocket Lab Corporation (RKLB) was up +2.83% at $78.14. The stock exceeded the S&P 500, which registered a gain of 0.64% for the day. Meanwhile, the Dow experienced a rise ...
24/7 Wall St. on MSN
Why Rocket Lab’s Sky-High Valuation Is a Big Risk in 2026
Rocket Lab (NASDAQ:RKLB) stock climbed about 30% in one week in December following reports of a planned SpaceX initial public ...
Rocket Lab Corporation ( RKLB) stock hit a record high on Dec. 23 after the company disclosed that it successfully launched its 21st Electron rocket in 2025. Year to date, the stock has more than ...
Rocket Lab’s stock closed at a record high Friday, its first since October, after the rocket-launch provider won its largest contract ever.
Rocket Lab (RKLB) has quietly turned into one of the market's stronger space names this year, with the stock up around 55% over the past month and 165% over the past year. See our latest analysis for ...
Rocket Lab Corporation (NASDAQ: RKLB) shares are trading marginally lower on Wednesday, pulling back from Tuesday’s move ...
Rocket Lab Corporation (NASDAQ:RKLB) jumped about 5% on early Monday after capping a record year with its 21st Electron rocket launch, sending the QPS-SAR-15 satellite for Japan's iQPS into orbit. The ...
The newly awarded contract nearly doubles Rocket Lab’s earlier $1.1B backlog reported at the end of Q3. Achieved a record of ...
Rocket Lab (RKLB) valuation vs growth: 48x revenue, mega satellite deal, Neutron delay, margin outlook and key chart levels.
Rocket Lab Corporation's stock rally is justified by government contracts, global expansion, and tech growth. Click here to read an analysis of RKLB stock now.
Rocket Lab's business has grown significantly in recent years, but it's still not profitable. The first launch of its larger Neutron rocket is expected later this year. After a stock skyrockets by ...
Rocket Lab stock is trading higher Tuesday, extending a 2025 rally as investors digested upbeat analyst commentary and a swelling defense backlog.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results